The development of treatment using neurofeedback for patients with mood disorder: an exploratory study through neuroimaging approaches - The development of treatment for mood disorder by NFB

Okada Go0 个研究点目标入组 130 人开始时间: 2019年2月26日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•[For patients/clients ]
•1) Aged 20-80 years old
•2) Being diagnosed as major depressive disorder or bipolar disorder (Type I, Type II) according to DSM-IV-TR or DSM-V criteria
•3) Present ongoing episode of major depressive symptoms
•4) Present treatment-resistance (scores 14 points or above out of 17 items on the Hamilton Rating Scale for Depression even after >=4 weeks of treatment with sufficient amount of more than 1 kinds of anti-depressants) or low treatment-tolerance (insufficient administration due to side-effects while taking more than 1 kinds of anti-depressants)
•5) Satisfactory informed consent obtained from the participant him/herself
•[For healthy control]
•1) Aged 20-80 years old
•2) Not history of psychiatric disorders
•3) Not having current serious medical illness
•Satisfactory informed consent obtained from the participant him/herself

•1) Decisionally impaired individuals who has diminished capacity to understand the aim of the research
•2) Physically impaired individuals who are not able to complete the experiment
•3) Subjects who are contraindicated for the use of MRI
•Having an implanted heart pace-maker
•Having implanted cerebral (arteries) clips
•Having implanted neural/nerve stimulators
•Having implanted pumps
•Having work experience in a metal industry or possibility of metal residues remaining in the body
•Having metal-tattoos (including tattooed eye-lining)
•Being pregnant, or having possibility of being pregnant
•4) Any individuals judged as inappropriate for the experiment by the principal investigator or a collaborating researcher.
•5)Those participating in other intervention studies

发起方

Okada Go